• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Health»Memory drug enters clinical trial, may help treat cognitive disorders

Memory drug enters clinical trial, may help treat cognitive disorders

Saheli 07 Apr 2016 Health Comments Off on Memory drug enters clinical trial, may help treat cognitive disorders 369 Views

A memory drug developed by the National Institutes of Health and Tetra Discovery Partners that may help treat or prevent cognitive disorders has been moved into a small clinical trial, the agency announced in a press release.

The drug, BPN14770, is aimed at improving a biochemical pathway responsible for memory and nerve synapse formation in the brain, unlike many drugs targeting the buildup of amyloid plaques that contribute to the development of Alzheimer’s disease and other cognitive disorders.

BPN14770 is the first drug to make it out of the NIH’s Blueprint Neurotherapeutics Network, which pairs scientists developing molecules with medical application with companies that have experience developing them into usable, marketable drugs.

“There is a great need for additional new drug targets and treatment approaches for Alzheimer’s disease that effectively reduce symptoms, and potentially also slow disease progression,” Dr. Scott Reines, chief medical officer of Tetra, said in a press release. “Most current Alzheimer’s disease drug development is focused on amyloid targeted approaches, which even if successful are likely to be more effective when used in combination with drugs addressing other mechanisms of the disease. The PDE4 biochemical pathway of memory and nerve synapse formation targeted by BPN14770 is well documented.”

Researchers will recruit 48 healthy volunteers to test the safety, tolerability, and pharmacokinetics of the drug in the body. Based on the results of the Phase 1 trial, the researchers will mount a multiple ascending dose study with young and elderly participants to begin assessing the short- and long-term effects of the drug.

“Researchers have shown great interest in exploring how boosting synapse formation can potentially benefit not only Alzheimer’s disease but also other cognitive disorders such as schizophrenia and learning/developmental disabilities, such as Fragile X syndrome,” Reines said. “We greatly look forward to advancing our clinical studies of BPN14770 to understand its potential in treating these serious neurological conditions, which represent enormous unmet medical needs.”

[Source:- UPI]

clinical cognitive disorders Drug enters help may memory treat trial 2016-04-07
Tags clinical cognitive disorders Drug enters help may memory treat trial
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Saheli
Previous Article :

Metro trains with no drivers soon

Next Article :

Not willing to take anymore chances, govt. keeps paper-setters incommunicado

Related Articles

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time

admin 04 Oct 2025
Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members

Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members

admin 15 Sep 2025
How is PSA used to monitor prostate cancer?

How is PSA used to monitor prostate cancer?

admin 01 Sep 2025

Latest Post

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time
Health

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time

admin 04 Oct 2025

Michael Kremer on the Andhra Pradesh PAL Study’s evidence of personalized adaptive learning in India

admin 22 Sep 2025
Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members
Health

Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members

admin 15 Sep 2025
Small, Rural Central California High School Continues To Defy Standardized Education
Education

Small, Rural Central California High School Continues To Defy Standardized Education

admin 12 Sep 2025
Speeches delivered by CEO Sundar Pichai at the White House AI Education Taskforce
Education

Speeches delivered by CEO Sundar Pichai at the White House AI Education Taskforce

admin 08 Sep 2025
How is PSA used to monitor prostate cancer?
Health

How is PSA used to monitor prostate cancer?

admin 01 Sep 2025
The Future of High Performance Networking: Ultra Ethernet Explained
Technology

The Future of High Performance Networking: Ultra Ethernet Explained

admin 28 Aug 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme